Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02016430

Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Our group has recently identified the association between gut-flora-mediated carnitine and phosphatidylcholine metabolism, specifically trimethylamine-N-oxide (TMAO), and cardiovascular risk. This study investigates the ability for dietary intervention to modulate TMAO levels.

Detailed description

This is a pilot human study to characterize the relationship between gut flora-associated TMAO generation and dietary intervention. The investigators hypothesize that tailored dietary interventions may help to reduce the ability for gut flora to generate TMAO in individuals with elevated TMAO levels. Specific aims include: 1. To investigate the proportion of subjects with persistently elevated circulating TMAO levels. 2. To compare the amount of TMAO generated from gut flora using stable-isotope-labelled choline, carnitine, and betaine in subjects with elevated versus normal circulating TMAO levels. 3. To evaluate the effect of dietary interventions on the amount of TMAO generated from gut flora using stable-isotope-labelled choline, carnitine, and betaine in subjects with elevated circulating TMAO levels.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMeLT Dietary interventionMediterranean diet containing food with low TMAO content.
BEHAVIORALTLC Dietary interventionStandard American Heart Association (AHA) recommendations for dietary counseling.
BEHAVIORALMeLT dietary intervention with TMAOMediterranean diet containing food with low TMAO content with TMAO levels provided to the subject for guidance.

Timeline

Start date
2014-04-04
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2013-12-20
Last updated
2025-10-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02016430. Inclusion in this directory is not an endorsement.